|Podcasts|August 5, 2021

Episode 88: The Science of Starting a Biotech

Yan Chen, CEO of Elpis Biopharmaceuticals, discusses how she transformed her scientific background into launching her own biotech.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe

Related Content

Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration

ByMike Hollan

June 24th 2026

Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

ByMike Hollan

June 23rd 2026

Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion

ByMike Hollan

June 22nd 2026

Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010

ByNicholas Jacobus

June 19th 2026

Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive

ByNicholas Jacobus

June 18th 2026

Episode 88: The Science of Starting a Biotech

Related Content

Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration

Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion

Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010

Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive

Trending on PharmExec

The Economics of the 340B Drug Pricing Program: Strategic Imperatives for the Life Sciences Industry in 2026

Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

How 3D Printing Speeds Up Drug Production

FDA Pilot Targets Faster Early-Stage Drug Trial Starts

The Next Evolution of Class of Trade: Why Customer Identity Is Becoming Market Access’s Hardest Problem